Data completeness
1/8 — Limited
Drug data last refreshed 12h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TURGEX (hexachlorophene) is a topical antimicrobial emulsion approved as an NDA by R-Pharm US. Hexachlorophene is a halogenated bisphenol compound with broad-spectrum antimicrobial activity used historically for skin antisepsis and antimicrobial wound care. The drug functions as a bacteriostatic agent with activity against gram-positive and gram-negative bacteria.
Pre-Launch
As a pre-launch product with no current market presence, the commercial team will be small and focused on launch preparation, regulatory submissions, and market access strategy.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
R-Pharm US is hiring 4 roles related to this product
Worked on TURGEX at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.